The largest database of trusted experimental protocols

Protein a sepharose cl 4b column

Manufactured by GE Healthcare

Protein A-Sepharose CL-4B column is a chromatography resin used for the purification of antibodies. It consists of Protein A, a bacterial protein, covalently coupled to Sepharose CL-4B beads. The column can be used to selectively bind and capture antibodies from complex mixtures, allowing for their isolation and purification.

Automatically generated - may contain errors

4 protocols using protein a sepharose cl 4b column

1

Antibody-Drug Conjugate ama-HEA125 Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody-drug conjugate ama-HEA125 was constructed by coupling of α-Amanitin to lysine residues of HEA125 antibody by a stable linker structure. HEA125 binds to EpCAM-expressing cells with high affinity (Kd ~ 2.2 × 10−9 mol L−1) and high specificity. HEA125 was purified by affinity chromatography using a protein A-Sepharose CL-4B column (GE Healthcare). α-Amanitin was attached to immunoglobulin molecules by a plasma stable urea linkage intended to release free α-Amanitin inside the tumour cell after lysosomal degradation of the antibody moiety. The drug-antibody ratio (DAR) of the α-Amanitin:IgG molecule was 4:1. Biochemical characteristics of ama-HEA125 were evaluated by high performance liquid chromatography (HPLC) using a PlatinBlue HPLC system (Knauer). In addition, HEA125 and ama-HEA125 were analysed by reducing SDS-PAGE and Coomassie staining according to common procedures. Verification of drug-loading was done by anti-amanitin immunoblotting analysis of 30 ng HEA125 and ama-HEA125 using standard techniques.
+ Open protocol
+ Expand
2

Immunoprecipitation and Immunoblotting Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoprecipitation and immunoblotting analyses were performed as previously described (30 (link)). Briefly, tissues or cells were homogenized in a buffer containing 50 mM tris-HCl (pH 7.5), 0.5% Triton X-100, 0.15 M NaCl, 4 mM EDTA, 4 mM EGTA, 1 mM Na3VO4, 50 mM NaF, 1 mM dithiothreitol, and protease inhibitors (trypsin inhibitor, pepstatin A, and leupeptin). For immunoprecipitation, lysates were incubated for 2 hours at 4°C with the indicated antibodies on a Protein A Sepharose CL-4B column (GE Healthcare Life Sciences) in homogenization buffer. The immunoprecipitates were washed thrice with homogenization buffer; equivalent amounts of protein were separated with SDS-PAGE, and proteins were then transferred to an Immobilon polyvinylidene difluoride membrane. Membranes were blocked with Tris Buffered Saline with Tween®20 (TBST) solution [50 mM tris-HCl (pH 7.5), 150 mM NaCl, and 0.1% Tween 20] containing 5% fat-free milk powder for 1 hour at room temperature and then incubated overnight at 4°C with the indicated primary antibodies. The membranes were then washed and incubated with the appropriate HRP-conjugated secondary antibody diluted in TBST. Blots were developed using an ECL immunoblotting detection system (Amersham Biosciences). Immunoreactive bands were visualized using the luminescent image analyzer LAS-4000 (Fujifilm).
+ Open protocol
+ Expand
3

Monoclonal Antibody Production and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
All monoclonal antibodies were produced and purified in-house, except the anti-His-tag antibody. The origin of the commercial antibodies used as secondary reagents in the ELISAs is mentioned in the corresponding sections of the “Methods.” Antibodies MF14, MF16, and MF1 were obtained from hybridoma supernatants, grown in ClonaCell HT medium (Stem Cell Technologies, cat # 03805). Antibodies MPE8, ADI-15614, and ADI-18992 were obtained from supernatants of Expi293 cells (Invitrogen) transiently co-transfected with plasmids encoding antibody heavy and light chains, and grown in Expi293 expression medium (cat # A14351-01). Antibodies were purified from supernatants using ammonium sulfate precipitation followed by affinity purification over a protein A-Sepharose CL-4B column (GE Healthcare, cat # 17-0780-01) as recommended by the manufacturer. The VRC-8400 plasmid backbone encoding the heavy and light chains for MPE8, ADI-15614, and ADI-18992 was obtained from the Vaccine Research Center (VRC) at the National Institutes of Health (NIH).
+ Open protocol
+ Expand
4

Antibody-Drug Conjugate ama-HEA125 Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody-drug conjugate ama-HEA125 was constructed by coupling of α-Amanitin to lysine residues of HEA125 antibody by a stable linker structure. HEA125 binds to EpCAM-expressing cells with high affinity (Kd ~ 2.2 × 10−9 mol L−1) and high specificity. HEA125 was purified by affinity chromatography using a protein A-Sepharose CL-4B column (GE Healthcare). α-Amanitin was attached to immunoglobulin molecules by a plasma stable urea linkage intended to release free α-Amanitin inside the tumour cell after lysosomal degradation of the antibody moiety. The drug-antibody ratio (DAR) of the α-Amanitin:IgG molecule was 4:1. Biochemical characteristics of ama-HEA125 were evaluated by high performance liquid chromatography (HPLC) using a PlatinBlue HPLC system (Knauer). In addition, HEA125 and ama-HEA125 were analysed by reducing SDS-PAGE and Coomassie staining according to common procedures. Verification of drug-loading was done by anti-amanitin immunoblotting analysis of 30 ng HEA125 and ama-HEA125 using standard techniques.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!